Cargando…

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals

Detalles Bibliográficos
Autores principales:	Koester, Ulli, van der Meulen, Nicholas
Publicado:	2018
Materias:	Detectors and Experimental Techniques
Acceso en línea:	http://cds.cern.ch/record/2643527

Ejemplares similares

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Köster, Ulli
Publicado: (2017)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Domnanich, Katharina, et al.
Publicado: (2014)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Airaksinen, A, et al.
Publicado: (2016)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Dorrer, H, et al.
Publicado: (2011)

Development and optimization of targeted radionuclide tumor therapy using folate based radiopharmaceuticals
por: Reber, Josefine Astrid
Publicado: (2015)

An innovative gamma-ray spectrometry system using a compact and portable CZT detector for radionuclidic purity tests of PET radiopharmaceuticals
por: Vichi, Sara, et al.
Publicado: (2016)

Terbium-149 for targeted alpha therapy
por: Grundler, Pascal, et al.
Publicado: (2023)

Preclinical in vivo application of $^{152}$Tb-DOTANOC: a radiolanthanide for PET imaging
por: Müller, Cristina, et al.
Publicado: (2016)

International Committee for Radionuclide Metrology Symposium on Radionuclide Metrology and its Applications
por: Bortel, G, et al.
Publicado: (1994)

Production of Long-Lived Radionuclides in CMS
por: Huhtinen, Mika, et al.
Publicado: (1998)

Radiopharmaceuticals and other compounds labelled with short-lived radionuclides
por: Welch, Michael J
Publicado: (2013)

Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013)

(188)Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy
por: Boschi, Alessandra, et al.
Publicado: (2017)

Terbium-149 for targeted alpha therapy
por: Borgna, Francesca, et al.
Publicado: (2021)

International Summer School on Man-made Radionuclides in the Environment
Publicado: (1990)

Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges
por: Salih, Suliman, et al.
Publicado: (2022)

Off-line separation of reactor produced $^{169}$Er for medical applications
por: Formento Cavaier, Roberto, et al.
Publicado: (2017)

MIRACLS- the Multi Ion Reﬂection Apparatus for Collinear Laser Spectroscopy of radionuclides
por: Malbrunot-Ettenauer, S
Publicado: (2020)

Optimisation of clinical SPECT imaging with 155Tb for theragnostic radionuclide therapy
por: Cocolios, Thomas Elias, et al.
Publicado: (2016)

Study of the kinetics of complex formation and in vivo stability of novel radiometal-chelate conjugates for applications in nuclear medicine
por: Radchenko, Valery, et al.
Publicado: (2017)

Benchmarking of a Multi Ion Reflection Apparatus for Collinear Laser Spectroscopy of radionuclides
por: Malbrunot-Ettenauer, Stephan
Publicado: (2017)

Innovative radiopharmaceuticals in oncology and neurology
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2017)

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Lutathera(®): The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
por: Hennrich, Ute, et al.
Publicado: (2019)

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
por: Holik, Holis Abdul, et al.
Publicado: (2022)

Au-198m as novel PAC probe
por: Correia, Guilherme, et al.
Publicado: (2023)

Development of innovative silicon radiation detectors
por: Balbuena, JuanPablo
Publicado: (2013)

Production and characterization of no-carrier-added (161)Tb as an alternative to the clinically-applied (177)Lu for radionuclide therapy
por: Gracheva, Nadezda, et al.
Publicado: (2019)

Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology
por: Barbet, Jacques, et al.
Publicado: (2017)

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application
por: Müller, Cristina, et al.
Publicado: (2018)

Proposal for an experiment with fast muons at CERN: determination of cross sections of fast muon induced reactions to cosmogenic radionuclides
por: Hartmann, F J, et al.
Publicado: (1995)

Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides
por: Li, Wei Bo, et al.
Publicado: (2022)

Production and separation of (43)Sc for radiopharmaceutical purposes
por: Domnanich, Katharina A., et al.
Publicado: (2017)

Novel Prodrugs for Targeting Diagnostic and Therapeutic Radionuclides to Solid Tumors
por: Kassis, Amin I., et al.
Publicado: (2008)

Innovative radioisotopes for preclinical and clinical studies in nuclear medicine
por: Assmann Walter, LMU Munich, et al.
Publicado: (2010)

Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate
por: Haller, Stephanie, et al.
Publicado: (2016)

Innovative applications and developments of micro-pattern gaseous detectors
por: Francke, Tom, et al.
Publicado: (2014)

New Radionuclides and Technological Advances in SPECT and PET Scanners
por: van der Meulen, Nicholas P., et al.
Publicado: (2021)

Palmitic Acid-Conjugated Radiopharmaceutical for Integrin α(v)β(3)-Targeted Radionuclide Therapy
por: Yang, Guangjie, et al.
Publicado: (2022)

Innovative instrumentation
por: Hyams, Bernard David
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_j8bnlvnen3ttddmais58nu6v4a